CoA Therapeutics

CoA Therapeutics is a biopharmaceutical company developing small-molecules designed to increase Coenzyme-A (CoA) levels in genetic disorders where CoA deficiency is implicated. It focuses on PKAN (pantothenate kinase-associated neurodegeneration), organic acidurias, and other diseases of CoA sequestration.